HEADER HYDROLASE (O-GLYCOSYL) 25-NOV-95 1CB2 TITLE CELLOBIOHYDROLASE II, CATALYTIC DOMAIN, MUTANT Y169F COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELLOBIOHYDROLASE II; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC; COMPND 5 SYNONYM: CBH II (Y169F); COMPND 6 EC: 3.2.1.91; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HYPOCREA JECORINA; SOURCE 3 ORGANISM_TAXID: 51453; SOURCE 4 GENE: CBH2 (Y169F); SOURCE 5 EXPRESSION_SYSTEM: HYPOCREA JECORINA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 51453; SOURCE 7 EXPRESSION_SYSTEM_GENE: CBH2 (Y169F) KEYWDS HYDROLASE (O-GLYCOSYL), GLYCOSIDASE, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.J.KLEYWEGT,M.SZARDENINGS,T.A.JONES REVDAT 7 03-NOV-21 1CB2 1 SEQADV HETSYN REVDAT 6 29-JUL-20 1CB2 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 13-JUL-11 1CB2 1 VERSN REVDAT 4 24-FEB-09 1CB2 1 VERSN REVDAT 3 01-APR-03 1CB2 1 JRNL REVDAT 2 19-MAR-99 1CB2 1 JRNL REVDAT 1 14-OCT-96 1CB2 0 JRNL AUTH A.KOIVULA,T.REINIKAINEN,L.RUOHONEN,A.VALKEAJARVI, JRNL AUTH 2 M.CLAEYSSENS,O.TELEMAN,G.J.KLEYWEGT,M.SZARDENINGS, JRNL AUTH 3 J.ROUVINEN,T.A.JONES,T.T.TEERI JRNL TITL THE ACTIVE SITE OF TRICHODERMA REESEI CELLOBIOHYDROLASE II: JRNL TITL 2 THE ROLE OF TYROSINE 169. JRNL REF PROTEIN ENG. V. 9 691 1996 JRNL REFN ISSN 0269-2139 JRNL PMID 8875646 JRNL DOI 10.1093/PROTEIN/9.8.691 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.ROUVINEN,T.BERGFORS,T.TEERI,J.K.KNOWLES,T.A.JONES REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF CELLOBIOHYDROLASE II FROM REMARK 1 TITL 2 TRICHODERMA REESEI REMARK 1 REF SCIENCE V. 249 380 1990 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 40828 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5492 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 210 REMARK 3 SOLVENT ATOMS : 392 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.250 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.110 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CB2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172204. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-APR-93 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HAMLIN REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46849 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.90000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE CATALYTIC CORE STARTS AT RESIDUE 83. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 83 REMARK 465 GLY A 84 REMARK 465 SER B 83 REMARK 465 GLY B 84 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 140 0.21 -67.94 REMARK 500 ASN A 161 57.15 -145.08 REMARK 500 PHE A 169 78.17 -151.06 REMARK 500 ASP A 170 35.02 -155.59 REMARK 500 ASP A 189 59.27 -109.41 REMARK 500 TYR A 209 50.94 -107.92 REMARK 500 GLU A 219 78.76 39.94 REMARK 500 SER A 222 -81.45 -117.94 REMARK 500 TRP A 269 -67.66 -109.94 REMARK 500 GLN A 319 125.01 -39.59 REMARK 500 ASN A 369 51.80 37.62 REMARK 500 ASP B 140 0.25 -67.98 REMARK 500 ASN B 161 57.18 -145.12 REMARK 500 PHE B 169 78.13 -151.06 REMARK 500 ASP B 170 35.00 -155.59 REMARK 500 ASP B 189 59.22 -109.39 REMARK 500 TYR B 209 50.92 -107.91 REMARK 500 GLU B 219 78.78 39.90 REMARK 500 SER B 222 -81.45 -117.95 REMARK 500 TRP B 269 -67.69 -109.98 REMARK 500 GLN B 319 125.00 -39.54 REMARK 500 ASN B 369 51.76 37.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ST1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE INCLUDING MUTATED TYR-> PHE. REMARK 800 REMARK 800 SITE_IDENTIFIER: ST2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE INCLUDING MUTATED TYR-> PHE. DBREF 1CB2 A 83 447 UNP P07987 GUX2_TRIRE 107 471 DBREF 1CB2 B 83 447 UNP P07987 GUX2_TRIRE 107 471 SEQADV 1CB2 PHE A 169 UNP P07987 TYR 193 ENGINEERED MUTATION SEQADV 1CB2 PHE B 169 UNP P07987 TYR 193 ENGINEERED MUTATION SEQRES 1 A 365 SER GLY THR ALA THR TYR SER GLY ASN PRO PHE VAL GLY SEQRES 2 A 365 VAL THR PRO TRP ALA ASN ALA TYR TYR ALA SER GLU VAL SEQRES 3 A 365 SER SER LEU ALA ILE PRO SER LEU THR GLY ALA MET ALA SEQRES 4 A 365 THR ALA ALA ALA ALA VAL ALA LYS VAL PRO SER PHE MET SEQRES 5 A 365 TRP LEU ASP THR LEU ASP LYS THR PRO LEU MET GLU GLN SEQRES 6 A 365 THR LEU ALA ASP ILE ARG THR ALA ASN LYS ASN GLY GLY SEQRES 7 A 365 ASN TYR ALA GLY GLN PHE VAL VAL PHE ASP LEU PRO ASP SEQRES 8 A 365 ARG ASP CYS ALA ALA LEU ALA SER ASN GLY GLU TYR SER SEQRES 9 A 365 ILE ALA ASP GLY GLY VAL ALA LYS TYR LYS ASN TYR ILE SEQRES 10 A 365 ASP THR ILE ARG GLN ILE VAL VAL GLU TYR SER ASP ILE SEQRES 11 A 365 ARG THR LEU LEU VAL ILE GLU PRO ASP SER LEU ALA ASN SEQRES 12 A 365 LEU VAL THR ASN LEU GLY THR PRO LYS CYS ALA ASN ALA SEQRES 13 A 365 GLN SER ALA TYR LEU GLU CYS ILE ASN TYR ALA VAL THR SEQRES 14 A 365 GLN LEU ASN LEU PRO ASN VAL ALA MET TYR LEU ASP ALA SEQRES 15 A 365 GLY HIS ALA GLY TRP LEU GLY TRP PRO ALA ASN GLN ASP SEQRES 16 A 365 PRO ALA ALA GLN LEU PHE ALA ASN VAL TYR LYS ASN ALA SEQRES 17 A 365 SER SER PRO ARG ALA LEU ARG GLY LEU ALA THR ASN VAL SEQRES 18 A 365 ALA ASN TYR ASN GLY TRP ASN ILE THR SER PRO PRO SER SEQRES 19 A 365 TYR THR GLN GLY ASN ALA VAL TYR ASN GLU LYS LEU TYR SEQRES 20 A 365 ILE HIS ALA ILE GLY PRO LEU LEU ALA ASN HIS GLY TRP SEQRES 21 A 365 SER ASN ALA PHE PHE ILE THR ASP GLN GLY ARG SER GLY SEQRES 22 A 365 LYS GLN PRO THR GLY GLN GLN GLN TRP GLY ASP TRP CYS SEQRES 23 A 365 ASN VAL ILE GLY THR GLY PHE GLY ILE ARG PRO SER ALA SEQRES 24 A 365 ASN THR GLY ASP SER LEU LEU ASP SER PHE VAL TRP VAL SEQRES 25 A 365 LYS PRO GLY GLY GLU CYS ASP GLY THR SER ASP SER SER SEQRES 26 A 365 ALA PRO ARG PHE ASP SER HIS CYS ALA LEU PRO ASP ALA SEQRES 27 A 365 LEU GLN PRO ALA PRO GLN ALA GLY ALA TRP PHE GLN ALA SEQRES 28 A 365 TYR PHE VAL GLN LEU LEU THR ASN ALA ASN PRO SER PHE SEQRES 29 A 365 LEU SEQRES 1 B 365 SER GLY THR ALA THR TYR SER GLY ASN PRO PHE VAL GLY SEQRES 2 B 365 VAL THR PRO TRP ALA ASN ALA TYR TYR ALA SER GLU VAL SEQRES 3 B 365 SER SER LEU ALA ILE PRO SER LEU THR GLY ALA MET ALA SEQRES 4 B 365 THR ALA ALA ALA ALA VAL ALA LYS VAL PRO SER PHE MET SEQRES 5 B 365 TRP LEU ASP THR LEU ASP LYS THR PRO LEU MET GLU GLN SEQRES 6 B 365 THR LEU ALA ASP ILE ARG THR ALA ASN LYS ASN GLY GLY SEQRES 7 B 365 ASN TYR ALA GLY GLN PHE VAL VAL PHE ASP LEU PRO ASP SEQRES 8 B 365 ARG ASP CYS ALA ALA LEU ALA SER ASN GLY GLU TYR SER SEQRES 9 B 365 ILE ALA ASP GLY GLY VAL ALA LYS TYR LYS ASN TYR ILE SEQRES 10 B 365 ASP THR ILE ARG GLN ILE VAL VAL GLU TYR SER ASP ILE SEQRES 11 B 365 ARG THR LEU LEU VAL ILE GLU PRO ASP SER LEU ALA ASN SEQRES 12 B 365 LEU VAL THR ASN LEU GLY THR PRO LYS CYS ALA ASN ALA SEQRES 13 B 365 GLN SER ALA TYR LEU GLU CYS ILE ASN TYR ALA VAL THR SEQRES 14 B 365 GLN LEU ASN LEU PRO ASN VAL ALA MET TYR LEU ASP ALA SEQRES 15 B 365 GLY HIS ALA GLY TRP LEU GLY TRP PRO ALA ASN GLN ASP SEQRES 16 B 365 PRO ALA ALA GLN LEU PHE ALA ASN VAL TYR LYS ASN ALA SEQRES 17 B 365 SER SER PRO ARG ALA LEU ARG GLY LEU ALA THR ASN VAL SEQRES 18 B 365 ALA ASN TYR ASN GLY TRP ASN ILE THR SER PRO PRO SER SEQRES 19 B 365 TYR THR GLN GLY ASN ALA VAL TYR ASN GLU LYS LEU TYR SEQRES 20 B 365 ILE HIS ALA ILE GLY PRO LEU LEU ALA ASN HIS GLY TRP SEQRES 21 B 365 SER ASN ALA PHE PHE ILE THR ASP GLN GLY ARG SER GLY SEQRES 22 B 365 LYS GLN PRO THR GLY GLN GLN GLN TRP GLY ASP TRP CYS SEQRES 23 B 365 ASN VAL ILE GLY THR GLY PHE GLY ILE ARG PRO SER ALA SEQRES 24 B 365 ASN THR GLY ASP SER LEU LEU ASP SER PHE VAL TRP VAL SEQRES 25 B 365 LYS PRO GLY GLY GLU CYS ASP GLY THR SER ASP SER SER SEQRES 26 B 365 ALA PRO ARG PHE ASP SER HIS CYS ALA LEU PRO ASP ALA SEQRES 27 B 365 LEU GLN PRO ALA PRO GLN ALA GLY ALA TRP PHE GLN ALA SEQRES 28 B 365 TYR PHE VAL GLN LEU LEU THR ASN ALA ASN PRO SER PHE SEQRES 29 B 365 LEU MODRES 1CB2 ASN A 289 ASN GLYCOSYLATION SITE MODRES 1CB2 ASN A 310 ASN GLYCOSYLATION SITE MODRES 1CB2 THR A 87 THR GLYCOSYLATION SITE MODRES 1CB2 THR A 97 THR GLYCOSYLATION SITE MODRES 1CB2 SER A 106 SER GLYCOSYLATION SITE MODRES 1CB2 SER A 109 SER GLYCOSYLATION SITE MODRES 1CB2 SER A 110 SER GLYCOSYLATION SITE MODRES 1CB2 SER A 115 SER GLYCOSYLATION SITE MODRES 1CB2 THR A 122 THR GLYCOSYLATION SITE MODRES 1CB2 ASN B 289 ASN GLYCOSYLATION SITE MODRES 1CB2 ASN B 310 ASN GLYCOSYLATION SITE MODRES 1CB2 THR B 87 THR GLYCOSYLATION SITE MODRES 1CB2 THR B 97 THR GLYCOSYLATION SITE MODRES 1CB2 SER B 106 SER GLYCOSYLATION SITE MODRES 1CB2 SER B 109 SER GLYCOSYLATION SITE MODRES 1CB2 SER B 110 SER GLYCOSYLATION SITE MODRES 1CB2 SER B 115 SER GLYCOSYLATION SITE MODRES 1CB2 THR B 122 THR GLYCOSYLATION SITE HET NAG A 501 14 HET NAG A 502 14 HET MAN A 503 11 HET MAN A 504 11 HET MAN A 505 11 HET MAN A 506 11 HET MAN A 507 11 HET MAN A 508 11 HET MAN A 509 11 HET NAG B 501 14 HET NAG B 502 14 HET MAN B 503 11 HET MAN B 504 11 HET MAN B 505 11 HET MAN B 506 11 HET MAN B 507 11 HET MAN B 508 11 HET MAN B 509 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 5 MAN 14(C6 H12 O6) FORMUL 21 HOH *392(H2 O) HELIX 1 1 ALA A 102 LEU A 111 1 10 HELIX 2 2 ILE A 113 SER A 115 5 3 HELIX 3 3 GLY A 118 LYS A 129 1 12 HELIX 4 4 LEU A 139 LYS A 157 5 19 HELIX 5 5 ILE A 187 ASP A 189 5 3 HELIX 6 6 GLY A 191 GLU A 208 1 18 HELIX 7 7 LEU A 223 THR A 228 5 6 HELIX 8 8 PRO A 233 GLN A 252 1 20 HELIX 9 9 PRO A 273 ASN A 289 1 17 HELIX 10 10 SER A 316 THR A 318 5 3 HELIX 11 11 GLU A 326 HIS A 340 1 15 HELIX 12 12 SER A 413 ALA A 416 5 4 HELIX 13 13 GLN A 432 THR A 440 1 9 HELIX 14 14 ALA B 102 LEU B 111 1 10 HELIX 15 15 ILE B 113 SER B 115 5 3 HELIX 16 16 GLY B 118 LYS B 129 1 12 HELIX 17 17 LEU B 139 LYS B 157 5 19 HELIX 18 18 ILE B 187 ASP B 189 5 3 HELIX 19 19 GLY B 191 GLU B 208 1 18 HELIX 20 20 LEU B 223 THR B 228 5 6 HELIX 21 21 PRO B 233 GLN B 252 1 20 HELIX 22 22 PRO B 273 ASN B 289 1 17 HELIX 23 23 SER B 316 THR B 318 5 3 HELIX 24 24 GLU B 326 HIS B 340 1 15 HELIX 25 25 SER B 413 ALA B 416 5 4 HELIX 26 26 GLN B 432 THR B 440 1 9 SHEET 1 A 7 MET A 134 LEU A 136 0 SHEET 2 A 7 GLY A 164 VAL A 168 1 N VAL A 167 O MET A 134 SHEET 3 A 7 THR A 214 ILE A 218 1 N LEU A 215 O GLY A 164 SHEET 4 A 7 VAL A 258 ASP A 263 1 N ALA A 259 O THR A 214 SHEET 5 A 7 LEU A 296 THR A 301 1 N ARG A 297 O MET A 260 SHEET 6 A 7 PHE A 346 ASP A 350 1 N PHE A 346 O LEU A 299 SHEET 7 A 7 LEU A 388 VAL A 392 1 N ASP A 389 O PHE A 347 SHEET 1 B 7 MET B 134 LEU B 136 0 SHEET 2 B 7 GLY B 164 VAL B 168 1 N VAL B 167 O MET B 134 SHEET 3 B 7 THR B 214 ILE B 218 1 N LEU B 215 O GLY B 164 SHEET 4 B 7 VAL B 258 ASP B 263 1 N ALA B 259 O THR B 214 SHEET 5 B 7 LEU B 296 THR B 301 1 N ARG B 297 O MET B 260 SHEET 6 B 7 PHE B 346 ASP B 350 1 N PHE B 346 O LEU B 299 SHEET 7 B 7 LEU B 388 VAL B 392 1 N ASP B 389 O PHE B 347 SSBOND 1 CYS A 176 CYS A 235 1555 1555 2.03 SSBOND 2 CYS A 368 CYS A 415 1555 1555 2.03 SSBOND 3 CYS B 176 CYS B 235 1555 1555 2.03 SSBOND 4 CYS B 368 CYS B 415 1555 1555 2.03 LINK OG1 THR A 87 C1 MAN A 503 1555 1555 1.44 LINK OG1 THR A 97 C1 MAN A 504 1555 1555 1.43 LINK OG SER A 106 C1 MAN A 505 1555 1555 1.43 LINK OG SER A 109 C1 MAN A 506 1555 1555 1.43 LINK OG SER A 110 C1 MAN A 507 1555 1555 1.43 LINK OG SER A 115 C1 MAN A 508 1555 1555 1.43 LINK OG1 THR A 122 C1 MAN A 509 1555 1555 1.43 LINK ND2 ASN A 289 C1 NAG A 501 1555 1555 1.45 LINK ND2 ASN A 310 C1 NAG A 502 1555 1555 1.45 LINK OG1 THR B 87 C1 MAN B 503 1555 1555 1.43 LINK OG1 THR B 97 C1 MAN B 504 1555 1555 1.43 LINK OG SER B 106 C1 MAN B 505 1555 1555 1.43 LINK OG SER B 109 C1 MAN B 506 1555 1555 1.43 LINK OG SER B 110 C1 MAN B 507 1555 1555 1.43 LINK OG SER B 115 C1 MAN B 508 1555 1555 1.43 LINK OG1 THR B 122 C1 MAN B 509 1555 1555 1.43 LINK ND2 ASN B 289 C1 NAG B 501 1555 1555 1.45 LINK ND2 ASN B 310 C1 NAG B 502 1555 1555 1.45 CISPEP 1 GLN A 357 PRO A 358 0 -0.67 CISPEP 2 GLN A 422 PRO A 423 0 -0.39 CISPEP 3 ASN A 443 PRO A 444 0 0.49 CISPEP 4 GLN B 357 PRO B 358 0 -0.65 CISPEP 5 GLN B 422 PRO B 423 0 -0.31 CISPEP 6 ASN B 443 PRO B 444 0 0.49 SITE 1 ST1 3 ASP A 175 ASP A 221 PHE A 169 SITE 1 ST2 3 ASP B 175 ASP B 221 PHE B 169 CRYST1 49.100 75.800 92.900 90.00 103.20 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020367 0.000000 0.004777 0.00000 SCALE2 0.000000 0.013193 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011056 0.00000 MTRIX1 1 0.994635 -0.096273 -0.037846 20.01249 1 MTRIX2 1 0.097060 0.995086 0.019549 45.14702 1 MTRIX3 1 0.035779 -0.023118 0.999092 45.34660 1